By Nanjinia Wamuswa
Leading pharmaceutical manufacturing company, GlaxoSmithKline, has cut of prices of its key essential drugs by about 50 per cent to improve access.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted